Darier disease (DD) is a genetic skin disease that is associated with mutations in the ATP2A2 gene encoding the type 2 sarco/endoplasmic reticulum (ER) Ca ] i through the inositol trisphosphate (IP3) receptor pathway and stimulated differentiation. In monolayer ATP2A2-silenced keratinocytes, although TIP39 increased cytosolic calcium from the ER, the response was incomplete compared with its control. TIP39 was observed to reduce intercellular clefts of the gene-silenced epidermal model but did not significantly upregulate keratinocyte differentiation genes such as keratin 10 and filaggrin.
| INTRODUCTION
Darier disease (DD), also known as Darier-White disease, dyskeratosis follicularis and keratosis follicularis, is an autosomal dominantly inherited skin disorder in which desmosomal adhesion between keratinocytes is abnormal. [1] [2] [3] A mutation of the ATP2A2 gene encoding type 2 sarco/endoplasmic reticulum (ER) Ca
is the primary genetic cause of this disease. [4] SERCA2 controls the transport of calcium ions from the cytosol into the lumen of the ER.
This gene mutation causes alterations of Ca 2+ homoeostasis and then induces loss of epidermal adhesion and dyskeratosis. [1, 2] Keratinocyte adhesion defects have been proposed to be due to the influence of SERCA2 on desmoplakin dynamics and intracellular adhesive strength through PKCα signalling, [5] and DD keratinocytes have been shown to display biochemical and morphological hallmarks of constitutive ER stress with increased sensitivity to ER stressors. [6] There are currently no validated curative treatments available for DD, with the majority of cases treated symptomatically. Lifestyle advice is very important, and topical steroids, vitamin D3 and oral retinoids are often used for DD therapies. For secondary bacterial and fungal infection, antibiotics and/or antifungal agents have been orally or topically administered. [7] Tuberoinfundibular peptide of 39 residues (TIP39) is a member of the parathyroid hormone (PTH) ligand family and an agonist of the PTH second receptor (PTH2R) which is known as a class b G protein-coupled receptor (GPCR). [8] Recently, we reported that TIP39 directly binds to PTH2R on the ER at low extracellular calcium conditions. [9] TIP39 regulates intracellular calcium ([Ca 2+ ] i ) of keratinocytes via PLC-inositol trisphosphate (IP3) receptor pathway. [9] Here, we have established a DD-like three-dimensional (3D) epidermal model by silencing ATP2A2 mRNA in keratinocytes and investigated the effects of TIP39 on calcium transport and epidermal structure in this model.
| MATERIALS AND METHODS

| Cells and reagents
Normal human epidermal keratinocytes (NHEK) were cultured as previously described. [9] Three-dimensional in vitro skin constructs were prepared as described. [10] TIP39 peptides (10 μM; Bachem Americas, Torrance, CA, USA) or control peptides (10 μM; GenScript, Piscataway, NJ, USA) were added to keratinocyte growth media for 6 days.
| Isolation of total RNA and quantitative RT-PCR
Total RNA from cultured keratinocytes and 3D in vitro skin constructs was extracted, and cDNA was synthesized as previously described. [9] TaqMan Gene Expression Assays (Thermo Fisher Scientific, Waltham, MA, USA) were used to analyse expression of human ATP2A2 (assay ID: Hs00544877_m1), human KRT5 (assay ID: Hs00361185_m1), human KRT10 (assay ID: Hs01043114_g1), human FLG (assay ID:
Hs00856927_g1) and human DSP (assay ID: Hs00950591_m1) as described by the manufacturer's instructions. Human GAPDH (assay ID:
Hs02758991_g1) was used as an internal control to validate RNA for each sample. Each mRNA expression was calculated as the relative expression to GAPDH, and all data are presented as fold change against each control (mean of non-stimulated cells).
| siRNA transfection to NHEK
ATP2A2 and control siRNA were purchased from GE Dharmacon (Lafayette, CO, USA). siRNA transfection was performed by the manufacturer's instructions of Lipofectamine ® RNAiMAX (Thermo Fisher Scientific). To silence ATP2A2 in a 3D skin construct, 300 pmol siRNA was transfected to 2×10 6 NHEK in 6-cm 2 culture dish. Cells were harvested at 18 hours after transfection and used for the production of the 3D skin construct as previously described.
[10]
| Western blot
Protein isolation and transfer were performed as previously described. [9] Anti-ATP2A2 (1 μg/mL; Santa Cruz, Dallas, TX, USA) and anti-GAPDH (1 μg/mL; North Acton, MA, USA) antibodies were used for protein detection. Six hundred and eighty nanometer and 800 nm IR-dye-conjugated secondary antibodies (1:10 000) and an Odyssey imager and quantification software (LI-COR Biosciences, Lincoln, NE, USA) were used for two-colour Western blotting to analyse both proteins on the same blot.
| Immunohistochemistry for paraffin-embedded sections
Immunohistochemistry staining (IHC) was performed as previously described. [11] Paraffin skin sections of DD were obtained from Kurume University (Kurume, Fukuoka, Japan). 4-μm paraffin sections were deparaffinized and rehydrated before heat-induced antigen retrieval was performed in 10 mM citrate buffer (pH 6.0 
| Immunofluorescence staining of cultured cells
Cells were fixed in −20°C cold methanol for 10 minutes then blocked with PBS containing 5% donkey serum at room temperature for 30 minutes. Immunostaining was performed as previously reported. [9] Anti-desmoplakin I+II (Abcam, Cambridge, MA, USA), secondary Alexa Fluor 488 or 594-conjugated antibodies (Thermo Fisher Scientific) were used at 1 μg/mL. Cover slips were mounted using ProLong ® Gold antifade reagent with DAPI (Thermo Fisher Scientific). Images were captured using a BX41 microscope (Olympus).
| Intracellular calcium image and measurements
Intracellular calcium measurement was performed as previously described. [9] NHEK were seeded at 4×10 4 /well (or 1×10 
| Statistical analysis
Data are expressed as means±SEM. Differences between experimental groups within each experiment were analysed using the unpaired Student's t test and were considered significant at P≤.05.
| RESULTS
| TIP39 increased cytosolic calcium from the endoplasmic reticulum and might improve SERCA activity after supplementation of calcium
The ER is the main dynamic Ca 2+ storage compartment of the cell. [12] [13] [14] We previously reported that exogenous TIP39 colocalized with the ER 5 minutes after application and increased [Ca
via Gα q -PLC-IP3 pathway at low extracellular calcium conditions. [9] Activated PLC is known to hydrolyse phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) to produce diacylglycerol (DAG) and IP3. DAG and the reduction in PI(4,5)P 2 levels directly contribute to the activation of transient receptor potential cation (TRPC) channels, while IP3 triggers Ca 2+ release from intracellular stores. [15] Therefore, these complex interactions suggest TIP39 might increase cytosolic calcium not only from the ER store but also from the ex- was 39.15% ( Figure 1E ). These data show that TIP39 increased cytoplasmic Ca 2+ from ER store in the absence of extracellular calcium. When extracellular calcium was added after TIP39 stimulation, ER Ca 2+ store was rapidly refilled in a time-dependent manner, a response likely aided by SERCA ( Figure S1A ). The depletion of ER Ca 2+ by TIP39 ( Figure 1E ) was completely rescued by 2.5 mM CaCl 2 in 10 minutes ( Figure 1G ). Those data suggest that TIP39 reduced ER Ca 2+ store, but it immediately improved SERCA activity after supplementation of extracellular calcium.
| The PTH2 receptor is expressed in the epidermis of DD
Previous data suggest that TIP39 may enhance SERCA activity in certain conditions. We therefore hypothesized that TIP39 may have the potential to rescue some of the aspects of abnormal calcium transport and cell differentiation seen in DD skin. First, we obtained DD skin sections from Dr. Nakama at Kurume University (Kurume), to evaluate the expression of PTH2R in these keratinocytes of patients with this disorder. Patient information is shown in Figure 2A . The patient has a mutation of E917 in L8-L9 domain or R131 in A domain. The previous research showed R131 mutation reduced the expression of SERCA2b protein about 70% compared with wild-type SERCA2b. [16] E917 mutation was not tested, but S916 or S920 mutation reduced about 80% activity of Ca 2+ -ATPase. [16] Those results suggest that both patients' amino mutation induces severe SERCA2 dysfunction.
The known histological features of DD including focal separation between suprabasal epidermal cells (acantholysis), suprabasal clefting and a distinctive dyskeratosis were seen in DD1 (Figure 2B middle) .
In DD2, widened epidermal cell-cell junction (spongiosis) was observed but acantholysis was not seen (Figure 2B right) . PTH2R was detected sparsely in control epidermis as previously described, but both DD1 epidermis and DD2 epidermis expressed PTH2R abundantly throughout keratinocytes in the epidermis ( Figure 2C , top and middle panels).
F I G U R E 1 TIP39 increased intracellular calcium from ER and enhanced SERCA activity after extracellular Ca 2+ supplementation. showed reduced desmoplakin expression ( Figure 3C ) as previously reported. [5] To evaluate interactions between the SERCA2 activity and activation of PTH2R, the effects of TIP39 on ATP2A2-knockdown NHEK (ATP2A2 KD) were studied. TIP39 peptide was first added to NHEK grown in monolayer. Figure 3D shows ATP2A2 silencing effects on cytoplasmic calcium in NHEK. The basic Fluo-4 fluorescence has no significant difference between two groups ( Figure 3D ). For analysing ATP2A2 silencing effects on Ca 2+ store in ER, ionomycin was used in the absence of extracellular calcium as in Figure 1D ( Figure 3E ). These data show ER calcium content was not affected by ATP2A2 silencing ( Figure 3E ).
ATP2A2 silencing delayed the Ca 2+ efflux from ER to cytoplasm by TIP39 and accelerated the closure of the reaction ( Figure 3F) . 
| TIP39 improved intercellular clefts without keratinization in an ATP2A2-silenced 3D epidermal model
Next, to evaluate the function of these cells when differentiated into a stratified model of human epidermis, NHEK were grown in 3D skin constructs on devitalized dermis. [10] 300 pmol siRNA was transfected to undifferentiated monolayer NHEK 18 hours before being seeded into constructs ( Figure S1B ). Both gene and protein expressions of ATP2A2 in 3D skin constructs were reduced in the construct transfected with target siRNA compared with its control (Figure 4A,B) .
Similar to the histological features of skin in DD, keratinocytes in this model of silenced ATP2A2 displayed dyskeratosis ( Figure 4C upper and middle panels), partial parakeratosis ( Figure 4C upper and bottom panels), suprabasal clefts ( Figure 4C middle panels) and abnormal cell-cell contact without reduction of E-cadherin ( Figure 4C bottom panels). Epidermal hyperplasia, a thickened granular layer, or hyperkeratosis was not seen. Having confirmed that DD epidermis expressed abundant PTH2R ( Figure 2C ), but also observing that
TIP39 could not maintain [Ca
2+
] i of ATP2A2 KD after 30 minutes of stimulation ( Figure 3H) , it was necessary to evaluate the role of SERCA2 as a potential mediator of TIP39 action in ATP2A2-silenced skin constructs. Previously, we reported that TIP39 induced terminal differentiation and increased stratum corneum thickness in the 3D skin construct. [9] In this experiment, TIP39 also increased granular cell layer in control skin construct (data not shown), but it did not have this effect on keratinocyte differentiation of ATP2A2-silenced cells 
| DISCUSSION
In this study, we report that TIP39 modulates ER calcium signalling and may have potential effects on DD. TIP39 induced a shift of Ca Vitamin D3 and the parathyroid hormone family member, PTHrP, can influence calcium homoeostasis in keratinocytes, but the specific mechanisms of action on keratinocyte differentiation remain unclear.
Topical vitamin D3 analogs are widely used for skin diseases such as psoriasis that manifest abnormalities of epidermal differentiation. influence clinical outcome. For example, topical vitamin D3 modulates development of immune cells and production of inflammatory cytokine in psoriasis skin. [11, [17] [18] [19] This immune regulation may be due to a direct effect of calcium signalling on immune cell activation or differentiation such as mast cells, neutrophils, macrophages, dendritic and T cells. [20] [21] [22] Darier disease often leads to secondary bacterial, fungal or viral infection of the skin. A limitation of the current study and model of DD is that these observations were made in a sterile environment, not in the physiological setting of active communication between resident skin microbes and the epidermis. Based on the phenotype observed in DD, it is likely that calcium signalling will either directly or indirectly influence host communication with bacteria by effects on immune cell function or epidermal penetration. [20] In the future, it will be necessary to adapt the DD-like 3D epidermal model reported here to further investigate the function of microbes in the skin. However, the current study further illustrates the utility of TIP39 as a molecule to influence calcium homoeostasis and the potential of 3D keratinocyte culture models to test therapies of genetic skin diseases.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. 
